Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Neuroimaging in multiple sclerosis].

V M Rivera1

  • 1Department of Neurology, Baylor College of Medicine, 6560 Fannin, Suite 1224, Houston, Texas 77030, USA. vrivera@bcm.tmc.edu

Revista De Neurologia
|April 20, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Therapeutic attitudes towards multiple sclerosis in Central America and the Caribbean facing the SARS-CoV-2 pandemia].

Neurologia·2020
Same author

Multiple sclerosis as a universal disease and the challenges to immigrants in high prevalence countries.

European journal of neurology·2018
Same author

A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.

The New England journal of medicine·2013
Same author

Phase I/IIa trial of the mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) administered orally in patients with refractory or advanced malignancies and sarcoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2012
Same author

Evaluation of a rapamycin-regulated serotype 2 adeno-associated viral vector in macaque parotid glands.

Oral diseases·2010
Same author

Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxel.

Annals of oncology : official journal of the European Society for Medical Oncology·2009
Same journal

The Correlation Between and Variability of Three Balance Scales in the Assessment of Balance Function in Patients With Ataxia.

Revista de neurologia·2026
Same journal

Surgical Treatment of an Aneurysm in the Subacute Stage of Hemorrhagic Moyamoya Disease: Aneurysm Resection Combined With STA-MCA Bypass: A Case Report.

Revista de neurologia·2026
Same journal

Mapping the Evidence: Central Sleep Apnea Syndromes During Sleep and Stroke-A Scoping Review.

Revista de neurologia·2026
Same journal

Developmental and Epileptic Encephalopathy Due to a Novel <i>ARHGEF9</i> Deletion Variant: Case Series of Two Siblings.

Revista de neurologia·2026
Same journal

P300 Event-Related Potentials as Cognitive Biomarkers in Neurological and Neuropsychiatric Disorders: A Systematic Review.

Revista de neurologia·2026
Same journal

[Effectiveness and Risk of Recurrence of Pulsed Radiofrequency in Trigeminal Neuralgia and Chronic Cluster Headache].

Revista de neurologia·2026
See all related articles

Magnetic resonance (MR) and evoked potentials are key tools for diagnosing multiple sclerosis (MS). These neuroimaging techniques aid in identifying MS-related changes and evaluating treatment response.

Area of Science:

  • Neurology
  • Immunology
  • Radiology

Context:

  • Multiple sclerosis (MS) is a destructive neurological disorder.
  • Genetic susceptibility plays a role in MS development.
  • Immune system alterations are characteristic of MS.

Purpose:

  • To describe the use of neuroimaging in diagnosing multiple sclerosis.
  • To highlight the role of Magnetic Resonance (MR) in MS diagnosis and treatment evaluation.
  • To discuss the complementary role of evoked potentials in detecting MS lesions.

Summary:

  • Magnetic Resonance (MR) is a fundamental technique for diagnosing multiple sclerosis (MS) and monitoring treatment efficacy.
  • Key MR techniques include T1, T2, FLAIR, gadolinium-enhanced T1, MR spectroscopy, and magnetization transfer MR.

Related Experiment Videos

  • Cerebrospinal fluid (CSF) analysis reveals immunological changes in over 50% of MS patients.
  • Evoked potentials can detect asymptomatic and MR-invisible lesions, aiding in diagnosis.

    • Impact:

    • Improved diagnostic accuracy for multiple sclerosis.
    • Enhanced understanding of MS pathophysiology through neuroimaging.
    • Facilitation of early detection and management of MS.